Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• COPD16Radon and COPD mortality in the American Cancer Society Cohort copdTurner26 passages
• COPD1A new class of bronchodilator improves lung function in COPD: a trial with GSK961081 A new class of bronchodilator improves lung function in COPDWielders27 passages
• COPD1Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study The SHINE study: dual bronchodilation with QVA149Bateman30 passages
• COPD1Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study copdKerwin Edward *Hébert Jacques #Gallagher Nicola ¶Martin Carmen ¶Overend Tim ¶Alagappan34 passages
• COPD1Lung function indices for predicting mortality in COPD Lung function indices for predicting mortality in COPDBoutou27 passages
• COPD1Simple functional performance tests and mortality in COPD Simple functional performance tests and mortality in COPDPuhan30 passages
• Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China5 The Stanford Center for Biomedical Informatics Research, Dept of Medicine, Stanford University, Stanford, CA, USA635 passages
• Centre (CCRC), University of Cologne, Cologne, Germany12 Division of Cardiology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico30 passages
• Centre, Oxford, UKSophie D. West, Newcastle Regional Sleep Service, Newcastle upon Tyne30 passages
• Centre, Riyadh, Saudi Arabia8 Dept of Dermatology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia9 University of Maryland School of Medicine, Baltimore, MD, USA1043 passages
• Centre, University of Gothenburg, Gothenburg, SwedenP.M. O’Byrne, Dept of Medicine,28 passages
• Centre, University of Leicester, Leicester, UK3 Dept of Cardiovascular Sciences, University of Leicester, Leicester, UK4 Heart of30 passages
• Council, Norwegian Asthma and Allergy Association (NAAF), Glaxo28 passages
• Eur Respir J5783 passages
• Fellowshiphttp://doi.org/MFE-135481Karolinska Institutet and AstraZeneca Joint Research Program in Translational Sciencehttp://doi.org/King32 passages
• Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, Spain5 National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and33 passages
• Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK4 Dept of Respiratory and General Medicine, East Lancashire31 passages
• Institute for Environmental Medicine (IUF), Düsseldorf15 Helmholtz Zentrum, München and German Research Centre for Environmental Health, Institute of40 passages
• Institute of Southeast Michigan, 29255 West 10 Mile Road,41 passages
• Institute of the McGill University Health Centre, Montreal, QC, Canada3 McGill International Tuberculosis Centre, Montreal, QC, Canada4 State University of Rio de Janeiro, Rio de Janeiro, Brazil539 passages
• Institute, Sir Charles Gairdner Hospital, Perth, Australia3 Institute for Breathing and Sleep, Austin Hospital, Heidelberg, Australia4 University of Melbourne, Parkville, Australia533 passages
• Institute, Tradate, Italy535 passages
• Institute, Tradate, Italy5 Both authors contributed equallyGiovanni Battista Migliori, WHO Collaborating Centre for TB and Lung Diseases,10 passages
• Institute, Tradate, Italy6 Public Health Consulting Group, Lugano, Switzerland7 These authors contributed equallyGiovanni Battista Migliori,12 passages
• Institute, Tradate, ItalyMukund Uplekar,33 passages
• Letters13Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis Pirfenidone effect on cough in idiopathic pulmonary fibrosisvan Manen13 passages
• Letters18Noninterventional statistical comparison of BTS and CHEST guidelines for size and severity in primary pneumothorax Hilar or apical size in primary pneumothoraxNikolić8 passages
• Letters2Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma Urokinase plasminogen activator receptor polymorphisms and asthmaIerodiakonou Despo 127Portelli9 passages
• Letters311Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population Low socioeconomic status associated with worse lung function in CFTaylor-Robinson11 passages
• Letters3Bile acid aspiration in people with cystic fibrosis before and after lung transplantation Aspiration in CF pre and post transplantationBrodlie Malcolm 12Aseeri Ali 13Lordan10 passages
• Letters4Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis Cross border, individualised treatment of a patient with XDR-TBAkkerman9 passages
• Letters4First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB Experience of effectiveness and safety of bedaquiline for XDR-TBLewis9 passages
• Letters4Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid Delamanid long-term mortality in MDR-TB patientsWells9 passages
• Letters4Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in10 passages
• LettersCircadian rhythm of exhaled biomarkers in health and asthma Circadian rhythm of exhaled biomarkers in health and asthmaWilkinson Maxim 1Maidstone Robert 234Loudon Andrew 5Blaikley John 16White11 passages
• LettersConcomitant medications and clinical outcomes in idiopathic pulmonary fibrosis Concomitant medications and clinical outcomes in IPFKreuter Michael 1https://orcid.org/0000-0001-5258-0228Lederer12 passages
• LettersDNA methylation modules in airway smooth muscle are associated with asthma severity DNA methylation modules in airway smooth muscle and asthma severityPerry14 passages
• LettersEffect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis Pirfenidone on breathlessness in IPF patientsGlassberg13 passages
• LettersEligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union Eligibility for shorter treatment of MDR-TB in the EUvan der Werf9 passages
• LettersJob strain and COPD exacerbations: an individual-participant meta-analysis Job strain and COPD exacerbationsHeikkilä Katriina 1Madsen12 passages
• LettersOpioids for breathlessness: psychological and neural factors influencing response variability Opioids for breathlessness: psychological and neural factorsAbdallah17 passages
• Non-Cystic Fibrosis Bronchiectasis3Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study36 passages
• Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases Nintedanib to treat progressive fibrosing interstitial lung diseasesWollin Lutz 1Distler Jörg H.W. 2Redente20 passages
• Program, Walter Reed Army Institute of Research, Silver Spring, MD, USAD. Falzon,38 passages
• Respiratory Biomedical Research Unit, Royal Brompton and21 passages
• Respiratory Infections4Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial Proadrenomedullin-enhanced triage in LRTIAlbrich37 passages
• Respiratory Infections94Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine Aetiology of paediatric pneumonia pre- and post-PCVElemraid29 passages
• Tuberculosis4Contact investigation for tuberculosis: a systematic review and meta-analysis tuberculosisFox40 passages
• Tuberculosis4Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper Dried plasma spots in TB diagnosis: IP-10 release assayAabye26 passages
• Tuberculosis4Role of the QuantiFERON®-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection tuberculosisMulder Christiaan van Deutekom Henk Huisman24 passages
• Tuberculosis4Tuberculosis treatment outcome monitoring in European Union countries: systematic review TUBERCULOSISvan Hest Rob *#Ködmön Csaba ¶Verver Suzanne *Erkens30 passages
• UK and UCL Cancer Trials Centre, London, UK18 Cardio-Respiratory Medicine, Leeds Teaching37 passages
• Unit at Royal Brompton and3 passages
• Unit, Montreal Chest Institute - Glen D5-2511, McGill University Health Centre, 1001 boul Decarie,33 passages
• Unit, Royal Brompton and73 passages
• Unit, University of Southampton Faculty of Medicine and University Hospital41 passages
• Unit, University of Southampton and University Hospital118 passages